Neurimmune's Corporate Minority Round

Neurimmune raised a round of funding on October 25, 2017. Investors include Biogen.

Neurimmune focuses on the development of immunotherapeutics for the treatment and prevention of human disorders with high unmet medical needs.…

Articles about Neurimmune's Corporate Minority Round: